Security key
75943R102
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)
CUSIP: 75943R102
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 246,546,186
- Total 13F value
- $4,577,983,154
- Share change
- +62,698,781
- Put/Call ratio
- 350%
- SEC-reported price per share
- $18.71
- Number of holders
- 256
- Value change
- +$1,171,111,045
- Number of buys
- 163
- Number of sells
- 93
- Shares outstanding
- 218,181,818
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
256
Top holders
10
RLAY full security history
Ownership snapshot
Full 13F holder table
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Casdin Capital, LLC
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
30 Jun 2026
13F
13D/G
Lead comparable stake: 7.5%
13D/G row: Casdin Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Casdin Capital, LLC leads the comparable SEC ownership view at 7.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Casdin Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Casdin Capital, LLC
7.5%
PERCEPTIVE ADVISORS LLC
6.4%
BlackRock, Inc.
6.1%
Commodore Capital LP
5.5%
SB INVESTMENT ADVISERS (UK) LTD
13%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Casdin Capital, LLC |
13F
13D/G
Company
|
7.5%
from 13D/G
|
$143,464,811
14,418,574 shares
|
— | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
6.4%
|
$264,208,883
14,106,187 shares
|
+$255,996,321 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
6.1%
from 13D/G
|
$129,104,225
12,975,299 shares
|
— | 31 Mar 2026 |
| Commodore Capital LP |
13D/G
13F
Company
|
5.5%
|
$224,760,000
12,000,000 shares
|
-$93,650,000 | 30 Jun 2026 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
13%
|
$277,654,382
27,904,963 shares
|
— | 31 Mar 2026 |
| Bellevue Group AG |
13F
Company
|
3.6%
|
$77,562,658
7,795,242 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
256
Shares
246,546,186
Rows available
256
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
242
Q2 2026 holders
256
Holder diff
14
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|